Caseware UK (AP4) 2024.0.164 2024.0.164 2024-03-30 2024-03-30 The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.2023-03-31 false No description of principal activity 2 2 true true 09605624 2023-03-31 2024-03-30 09605624 2022-03-31 2023-03-30 09605624 2024-03-30 09605624 2023-03-30 09605624 c:Director2 2023-03-31 2024-03-30 09605624 d:CurrentFinancialInstruments 2024-03-30 09605624 d:CurrentFinancialInstruments 2023-03-30 09605624 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-30 09605624 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-30 09605624 d:ShareCapital 2024-03-30 09605624 d:ShareCapital 2023-03-30 09605624 d:RetainedEarningsAccumulatedLosses 2024-03-30 09605624 d:RetainedEarningsAccumulatedLosses 2023-03-30 09605624 c:OrdinaryShareClass1 2023-03-31 2024-03-30 09605624 c:OrdinaryShareClass1 2024-03-30 09605624 c:OrdinaryShareClass1 2023-03-30 09605624 c:OrdinaryShareClass2 2023-03-31 2024-03-30 09605624 c:OrdinaryShareClass2 2024-03-30 09605624 c:OrdinaryShareClass2 2023-03-30 09605624 c:FRS102 2023-03-31 2024-03-30 09605624 c:AuditExempt-NoAccountantsReport 2023-03-31 2024-03-30 09605624 c:FullAccounts 2023-03-31 2024-03-30 09605624 c:PrivateLimitedCompanyLtd 2023-03-31 2024-03-30 09605624 d:Subsidiary1 2024-03-30 09605624 d:Subsidiary1 2023-03-31 2024-03-30 09605624 d:Subsidiary1 1 2023-03-31 2024-03-30 09605624 d:Subsidiary2 2024-03-30 09605624 d:Subsidiary2 2023-03-31 2024-03-30 09605624 d:Subsidiary2 1 2023-03-31 2024-03-30 09605624 6 2023-03-31 2024-03-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 09605624 MICADO HEALTHCARE LIMITED UNAUDITED FINANCIAL STATEMENTS INFORMATION FOR FILING WITH THE REGISTRAR FOR THE YEAR ENDED 30 MARCH 2024
MICADO HEALTHCARE LIMITED REGISTERED NUMBER: 09605624 BALANCE SHEET AS AT 30 MARCH 2024
|  | 2024 |  | 2023
Note |  | £ |  | £
Fixed assets |  |  |  |  |
Investments | 4 |  | 4 |  | 4
|  |  | 4 |  | 4
Current assets |  |  |  |  |
Debtors: amounts falling due within one year | 5 | 55,239 |  | 61,582 |
|  | 55,239 |  | 61,582 |
Creditors: amounts falling due within one year | 6 | (29,240) |  | (34,583) |
Net current assets |  |  | 25,999 |  | 26,999
Total assets less current liabilities |  |  | 26,003 |  | 27,003
Net assets |  |  | 26,003 |  | 27,003
Capital and reserves |  |  |  |  |
Called up share capital | 7 |  | 3 |  | 3
Profit and loss account |  |  | 26,000 |  | 27,000
|  |  | 26,003 |  | 27,003
The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime. The financial statements were approved and authorised for issue by the board and were signed on its behalf on 21 October 2025.
M Laryea-Bans
Page 1
MICADO HEALTHCARE LIMITED REGISTERED NUMBER: 09605624 BALANCE SHEET (CONTINUED) AS AT 30 MARCH 2024
Director
The notes on pages 3 to 5 form part of these financial statements. Page 2
MICADO HEALTHCARE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 MARCH 2024
1. | General information
Micado Healthcare Limited is a private company limited by shares and incorporated in England and Wales. The address of the registered office is 33 Brookfield Avenue, Ealing, London, United Kingdom,W5 1LA. The principal activity of the Company during the year was that of a holding company. 2.Accounting policies
| 2.1 | Basis of preparation of financial statements
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The following principal accounting policies have been applied:
| 2.2 | Valuation of investments
Investments in subsidiaries are measured at cost less accumulated impairment. Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Statement of Comprehensive Income for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment. Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.
| 2.3 | Debtors
Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.
| 2.4 | Creditors
Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
| 2.5 | Financial instruments
The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.
| 2.6 | Dividends
Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting. Page 3
MICADO HEALTHCARE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 MARCH 2024
3. | Employees
| The average monthly number of employees, including directors, during the year was 2 (2023 - 2).
4. | Fixed asset investments
|  | Investments in subsidiary companies
|  | £
| Cost or valuation |
| At 31 March 2023 | 4
| At 30 March 2024 | 4
| Subsidiary undertakings
| The following were subsidiary undertakings of the Company:
| Name | Class of shares | Holding
| Micado Homes Limited | Ordinary | 100%
| Micado Community living Services Limited | Ordinary | 100%
| The aggregate of the share capital and reserves as at 30 March 2024 and the profit or loss for the year ended on that date for the subsidiary undertakings were as follows:
| Name | Aggregate of share capital and reserves | Profit/(Loss)
|  | £ | £
| Micado Homes Limited | 6,621 | 36,682
| Micado Community living Services Limited | 2,337 | 63,748
Page 4
MICADO HEALTHCARE LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 MARCH 2024
5. | Debtors
|  |  |  |  | 2024 | 2023
|  |  |  |  | £ | £
| Other debtors | 55,239 | 61,582
|  | 55,239 | 61,582
6. | Creditors: Amounts falling due within one year
|  |  |  |  | 2024 | 2023
|  |  |  |  | £ | £
| Amounts owed to group undertakings | 29,236 | 34,579
| Other creditors | 4 | 4
|  | 29,240 | 34,583
7. | Share capital
|  |  |  |  | 2024 | 2023
|  |  |  |  | £ | £
|  | Allotted, called up and fully paid |  |
|  | 2 (2023 - 2) Ordinary shares of £1.00 each | 2 | 2
|  | 1 (2023 - 1) Ordinary 'C' shares share of £1.00 | 1 | 1
|  |  | 3 | 3
8. | Related party transactions
| Included in other debtors due within one year is an amount owed by the directors of £55,236 (2023: £61,579). The balance has been fully repaid after the year end. During the year the Company received dividends of £90,000 from investments in subsidiaries. The directors have an interest in dividends paid during the period of £91,000 (2023: £100,000).
9. | Controlling party
The ultimate parent undertaking is Micado Healthcare Limited, a company registered in England and Wales. The Company is jointly controlled by M Laryea-Bans and E A Adu. Page 5